Contact: +91-9711224068
International Journal of Applied Research
  • Multidisciplinary Journal
  • Printed Journal
  • Indexed Journal
  • Refereed Journal
  • Peer Reviewed Journal

ISSN Print: 2394-7500, ISSN Online: 2394-5869, CODEN: IJARPF

Impact Factor: RJIF 5.2

International Journal of Applied Research

Vol. 2, Issue 4, Part F (2016)

Effect of Monteleukast and Inhaled Corticosteroids in Asthma Disease: A Systemic Review

Author(s)
Ravneet Kaur, Sourabh kosey, Raj Kumar, Mandeep kaur
Abstract
Asthma is a chronic inflammatory disorder of the airways characterized by recurrent symptoms associated with airflow limitation and by bronchial hyper responsiveness. Inhaled corticosteroids, which suppress airway inflammation, are efficient in reducing symptoms and exacerbations, and often normalize lung function. The most commonly used drugs like monteleukast and budesonide (inhaled corticosteroids) are given for the treatment of Asthma. The diagnosis is confirmed with the spirometry, chest x-Ray, FEV1 (forced expiratory volume in one second). Patients have been carefully assessed and characterized in terms of diagnosis, severity of asthma, aggravating factors and associated diseases. Inhaled rapid-acting β2- agonists are the preferred reliever medications for the treatment of acute symptoms, and should be prescribed to all patients with asthma. ICSs are the most effective anti-inflammatory medications available for the treatment of asthma and represent the mainstay of therapy for most patients with the disease. Antileukotrienes are a new class of anti-inflammatory agents which either interfere with the leukotriene receptors or leukotriene production.
Pages: 370-374  |  429 Views  21 Downloads
How to cite this article:
Ravneet Kaur, Sourabh kosey, Raj Kumar, Mandeep kaur. Effect of Monteleukast and Inhaled Corticosteroids in Asthma Disease: A Systemic Review. International Journal of Applied Research. 2016; 2(4): 370-374.
Call for book chapter
International Journal of Applied Research